Atgam Efficacy and Safety in Moderate-to-Very Severe Acquired Aplastic Anemia: Outcome of a Large Multicenter Cohort of 634 Children and Adults from the French Authorization for Temporary Use Surveillance Program
Blood, 2023-11, Vol.142 (Supplement 1), p.1347-1347 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2023-186493
Full text available